Clinical trial Recruiting at 1 site Interventional Ages 18 to 80

Whole-body Cryotherapy for Fatigue in ME/CFS, Fibromyalgia, Long COVID

Official title: Whole-body Cryotherapy in Those With Chronic Fatigue: A Feasibility Study

Run by Oxford Brookes University · NCT07874217 · Data updated 2026-11-12

This study tests whether brief, repeated exposure to extreme cold can help reduce fatigue and related symptoms in adults with ME/CFS, fibromyalgia, or Long COVID compared to healthy controls.

Quick facts

Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment40 (estimated)
SponsorOxford Brookes University
Academic / other
Locations1 site (Oxford, Oxon)
StatusRecruiting
StartedOctober 5, 2026
Main results expectedJanuary 8, 2027
Study endsJanuary 8, 2027
Registry record updatedNovember 5, 2026
Trial IDNCT07874217 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–65 with ME/CFS, fibromyalgia, Long COVID, or healthy controls willing to undergo multiple cryotherapy sessions.

Probably not a fit

Patients unable to tolerate cold exposure or with contraindications to cryotherapy may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot feasibility study will enroll 40 adults (18–65 years) across four groups: healthy controls and individuals with ME/CFS, fibromyalgia, or Long COVID. Participants will undergo ten cryotherapy sessions over two weeks to assess tolerability, adherence, and the practicality of collecting outcome measures. The study aims to gather initial signals on symptom changes and inform future larger trials. The approach focuses on potential biological mechanisms such as autonomic balance, vascular function, inflammation, and cellular energy processes. No efficacy conclusions will be drawn from this small feasibility cohort.

Why it matters

Potential benefit: If successful, WBCT could offer a non-drug option to help manage fatigue and related symptoms in these conditions.

How similar studies have gone: Preliminary work in ME/CFS and related conditions suggests potential reductions in fatigue and improvements in autonomic regulation with cryotherapy, but this area is still exploratory.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* The study will recruit 40 adult participants (aged 18-65 years) divided across four groups: 10 healthy controls, 10 individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), 10 individuals with Fibromyalgia, and 10 individuals with Long COVID.

The relatively small group size is appropriate for a pilot feasibility study, where the primary aim is to assess recruitment, retention, tolerability of the intervention, and the practicality of completing the proposed outcome measures.

The sample size reflects the exploratory nature of the study, current resource availability and funding, and the intensive intervention schedule requiring ten visits over a two-week period. In addition, there is limited UK-based evidence regarding participant responses to whole-body cryotherapy within these clinical populations, further supporting a cautious, feasibility-focused sample size.

Exclusion Criteria:

* The primary physical risks relate to exposure to extreme cold during whole-body cryotherapy and minor discomfort associated with blood sampling. To mitigate these risks, all participants will undergo a structured medical screening using a standard WBCT medical questionnaire to identify contraindications (e.g. uncontrolled hypertension, cardiovascular disease, circulatory disorders such as Raynaud's disease, cryoglobulinaemia, severe respiratory disease, or claustrophobia). Individuals meeting exclusion criteria will not be enrolled.

Where it's running

  • Oxford Brookes University - Centre for Movement, Occupation and Rehabilitation Sciences (MOReS)
    Oxford, Oxon, United Kingdom
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.